GammaTileGammaTile

a brighter
outlook,
from day one

GammaTile® radiation therapy begins working when it’s needed most - immediately at the time of brain tumor removal surgery - so there’s no waiting, no daily interruptions, and no time lost.1 Just the peace of mind that comes from knowing you are already moving forward.

GammaTile is the
first and only
tile-based
radiation therapy
for the treatment of
operable brain tumors

Introducing the first-of-its-kind implantable radiation therapy. Placed at the time of your tumor removal surgery, GammaTile delivers highly concentrated and targeted radiation right at the source, to reduce tumor regrowth, protect healthy surrounding brain tissue, and limit potential side effects.2

FDA-cleared, bioresorbable collagen tile embedded with radiation sources that safely and precisely target any remaining cancer cells.1,2

Designed for operable brain tumors and indicated for patients with newly diagnosed malignant (cancerous) and recurrent brain tumors.

GammaTile is:1-3

  • Immediate: No radiation treatment delay
  • Targeted: Designed to protect healthy brain tissue
  • Controlled: Delivers more radiation dose directly to the tumor site

The tile structure provides spacing between the radiation and healthy brain tissue, improving safety by reducing exposure to surrounding areas, and because the tile is absorbable, there is no need for removal.1-3

Don’t just fight back.
Fight smart.

GammaTile is clinically proven to:

Reduce

the risk of tumor regrowth4-11

Protect

healthy surrounding brain tissue4-11

Minimize

side effects related to traditional radiation (including hair loss)2,12

LEARN MORE ABOUT GAMMATILE

What types of brain tumors does GammaTile treat?

GammaTile is FDA-cleared to treat a wide range of operable brain tumors, including:

  • Glioblastoma (newly diagnosed and recurrent)
  • Brain metastases (newly diagnosed and recurrent)
  • Meningiomas (recurrent)
LEARN MORE ABOUT BRAIN TUMOR TYPES

How does GammaTile work?

  • At the time of tumor removal surgery,

    your surgeon will place GammaTiles at the site where the tumor was removed

  • Immediately upon implantation,

    the GammaTiles begin delivering a targeted radiation dose to remaining tumor cells

    • Unlike traditional radiation which typically requires a 2 to 8-week wait time following surgery1

  • Over several weeks, GammaTile releases radiation,

    helping prevent tumor regrowth as you recover from surgery

    • The majority (~90%) of the GammaTile radiation treatment is delivered within the first 30 days11

  • Eventually, the collagen tiles safely

    dissolve in the body

SEE HOW GAMMATILE WORKS

Brain tumor education

Our goal is to help you feel more informed, more confident, and more in control of your treatment decisions. Visit our brain tumor education library to learn more about brain tumors, explore your treatment options, and gain the knowledge to make decisions that are right for you.

LEARN MORE

Is GammaTile right for you?

Do you have a brain tumor that can be removed with surgery? If so, you may benefit from GammaTile. See the list of important factors that can help you and your care team determine if GammaTile is the right option for you.

SEE IF YOU ARE A CANDIDATE

Hear from
GammaTile
patients

Discovering new treatment options gave me hope. It reminded me that there are more paths forward than you think. You are never stuck in one place. The future keeps moving, and so does the fight.

Danny
Danny
GammaTile patient

With GammaTile, the radiation seeds are laying right there against any cancer cells, so I knew this was going to be the best option available to me. I’ve just been thrilled with the outcome.

Joe
Joe
GammaTile patient

[My doctor] said there’s been a lot of success with this type of radiation therapy and I would not really have any hair loss. I was really interested.

Shannan
Shannan
GammaTile patient

Find a GammaTile Treatment Center Near You

Looking for a doctor who offers GammaTile? Use our center locator tool to connect with a specialist and further explore your treatment options.

FIND A TREATMENT CENTER

REFERENCES: 1. Gessler DJ, et al. Future Oncol. 16(30):2445-2455 (2020). 2. Kutuk T, et al. Brachytherapy. 23(6):751-760 (2024). 3. Garcia MA, et al. J Neurooncol. 166:203-212 (2024). 4. Kutuk T, et al. Brachytherapy. 22(6):872-881 (2023). 5. Dharnipragada R, et al. Neurooncol Adv. 5(1):vdad062 (2023). 6. Imber BS, et al. J Neurooncol. 159(3):609-618 (2022). 7. Nakaji P, et al. Cureus. 12(11):e11570 (2020). 8. Yekula A, et al. J Neurooncol. 166(3):441-450 (2024). 9. Gessler DJ, et al. Neurooncol Adv. 4(1):1-11 (2022). 10. Smith N, et al. Neuro Oncol. 24(S6):S4-S15 (2022). 11. Brachman DG, et al. J Neurosurg. 131(6):1819-1828 (2018). 12. GammaTile Registry. Data on File. GT Medical Technologies, Inc.
MKT-487-01